Details of the Drug

General Information of Drug (ID: DM417QZ)

Drug Name

RG6290

Synonyms

IMC-C103C

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT03973333) Safety and Efficacy of IMC-C103C as Monotherapy and in Combination With Atezolizumab. U.S. National Institutes of Health.